Filgrastim G CSF

Filgrastim G CSF Brand Names- Neupogen | Nivestym | Zarxio

What is Filgrastim G CSF

Filgrastim is a leukocyte growth factor that binds to cell surface receptors on hematopoietic cells stimulating proliferation, differentiation, commitment, and end cell functional activation.

It is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation. Efficacy for this indication was based on animal data in monkeys.

Filgrastim and the biosimilar products, filgrastim-sndz and filgrastim-aafi, are indicated to reduce the duration of neutropenia and incidence of infection in patients with non-myeloid malignancies or acute myelogenous leukemia receiving myelosuppressive chemotherapy and in patients with non-myeloid malignancies undergoing myeloablative chemotherapy followed by a bone marrow transplant; these products are also indicated for the mobilization of peripheral blood progenitor cells for collection by leukapheresis and for the treatment of severe chronic neutropenia.

Acute respiratory distress syndrome, fatal splenic rupture, and glomerulonephritis have occurred with filgrastim products

Indications

  1. aplastic anemia
  2. chemotherapy-induced neutropenia
  3. ganciclovir-induced neutropenia
  4. myelodysplastic syndrome (MDS)
  5. neutropenia
  6. peripheral blood stem cell (PBSC) mobilization
  7. radiation exposure

For the treatment of neutropenia

for the treatment of severe chronic congenital neutropenia

Filgrastim has been designated an orphan drug by the FDA for this indication.

Side Effects

  1. abdominal pain
  2. acute respiratory distress syndrome (ARDS)
  3. alopecia
  4. anaphylactoid reactions
  5. anemia
  6. angioedema
  7. anorexia
  8. antibody formation
  9. aortitis
  10. arthralgia
  11. asthenia
  12. azotemia
  13. back pain
  14. bleeding
  15. bone pain
  16. capillary leak syndrome
  17. chest pain (unspecified)
  18. constipation
  19. cough
  20. diarrhea
  21. dizziness
  22. dyspnea
  23. edema
  24. epistaxis
  25. erythema
  26. fatigue
  27. fever
  28. glomerulonephritis
  29. headache
  30. hematuria
  31. hemoptysis
  32. hypertension
  33. hypoalbuminemia
  34. hypoesthesia
  35. hypotension
  36. hypoxia
  37. infection
  38. insomnia
  39. leukocytosis
  40. maculopapular rash
  41. malaise
  42. muscle cramps
  43. musculoskeletal pain
  44. nausea
  45. osteoporosis
  46. peripheral edema
  47. proteinuria
  48. rash
  49. sickle-cell crisis
  50. splenic rupture
  51. splenomegaly
  52. thrombocytopenia
  53. vasculitis
  54. vomiting
  55. wheezing

Monitoring Parameters

  • CBC with differential
  • platelet count

Contraindications

  • breast-feeding
  • E. coli protein hypersensitivity
  • latex hypersensitivity
  • leukemia
  • leukocytosis
  • obstetric delivery
  • pregnancy
  • sickle cell disease
  • thrombocytopenia

Interactions

  • Abemaciclib
  • Aldesleukin, IL-2
  • Alemtuzumab
  • Alpha interferons
  • Altretamine
  • Antimetabolites
  • Bexarotene
  • Chlorambucil
  • Cladribine
  • Clofarabine
  • Cyclophosphamide
  • Denileukin Diftitox
  • Docetaxel
  • Estramustine
  • Fludarabine
  • Ibritumomab Tiuxetan
  • Lithium
  • Lomustine, CCNU
  • Mercaptopurine, 6-MP
  • Methotrexate
  • Natural Antineoplastics
  • Nelarabine
  • Paclitaxel
  • Pentostatin
  • Tositumomab
  • Tretinoin, ATRA
15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856